HEMOBLAST Pivotal Clinical Investigation
Public ClinicalTrials.gov record NCT02780869. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Prospective, Randomized, Controlled, Multicenter, Pivotal, Clinical Investigation Evaluating the Safety and Efficacy of HEMOBLAST Bellows in Cardiothoracic, Abdominal, and Orthopedic Lower Extremity Surgeries
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this prospective, randomized, controlled study is to evaluate the safety and efficacy of a new hemostatic device (HEMOBLAST™ Bellows) compared to a control device, absorbable gelatin sponge USP with thrombin.
Study identification
- NCT ID
- NCT02780869
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 258 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 21 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 18, 2016 (Actual)
- Primary completion
- Feb 1, 2017 (Actual)
- Completion
- Mar 27, 2017 (Actual)
- Last update posted
- Dec 27, 2018
2016 – 2017
United States locations
- U.S. sites
- 17
- U.S. states
- 11
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| CORE Institute | Phoenix | Arizona | — | — |
| University of California Los Angeles | Los Angeles | California | — | — |
| University of Southern California | Los Angeles | California | — | — |
| Lotus Clinical Research | Pasadena | California | — | — |
| Miami Plastic Surgery | Miami | Florida | — | — |
| Queens Medical Center | Honolulu | Hawaii | — | — |
| Suburban Hospital - Johns Hopkins Medicine | Bethesda | Maryland | 20814 | — |
| Washington University in St. Louis | St Louis | Missouri | — | — |
| Dartmouth Hitchcock Medical Center | Hanover | New Hampshire | — | — |
| Columbia University Medical Center / New York Presbyterian Hospital | New York | New York | — | — |
| Icahn School of Medicine at Mount Sinai | New York | New York | — | — |
| University of North Carolina at Chapel Hill | Chapel Hill | North Carolina | — | — |
| Duke University | Durham | North Carolina | — | — |
| Hunstad Kortesis Center | Huntsville | North Carolina | — | — |
| Intermountain Liver Disease and Transplant Center | Murray | Utah | — | — |
| University of Virginia | Charlottesville | Virginia | — | — |
| Spectrum Medical | Danville | Virginia | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02780869, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 27, 2018 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02780869 live on ClinicalTrials.gov.